Europe — EMA
Ondansetron Fresenius Kabi (Ondansetron Hydrochloride Dihydrate)
Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Fresenius Kabi, is a 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use.
Request sourcing
What is Ondansetron Hydrochloride Dihydrate?
Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Fresenius Kabi, is a 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It helps prevent nausea and vomiting caused by chemotherapy, radiotherapy, and surgery in adult and pediatric patients. GNH USA supplies Ondansetron Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.
GNH USA supplies Ondansetron Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.
What is Ondansetron Hydrochloride Dihydrate used for?
Ondansetron Fresenius Kabi is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.
- Chemotherapy‑induced nausea and vomiting: Reduces the frequency and severity of acute and delayed episodes. - Radiotherapy‑induced nausea and vomiting: Decreases vomiting associated with radiation treatment. - Post‑operative nausea and vomiting: Helps prevent nausea and vomiting after surgical procedures. - Pregnancy‑related nausea: Provides symptomatic relief for nausea during pregnancy, within clinical guidelines. - Hyper‑ -
